Laura Housman

    Head of Access, Outcomes and Population Health

    Joined Exact Sciences: 2019

    Key Responsibility: Drive access and value associated with Cologuard and future screening tests, while demonstrating the benefits of colon cancer screening in terms of outcomes and impact to potentially effected populations

    Previous Employment: Leadership roles at Novartis, Molecular Health, Charles River Laboratories, and Genzyme Genetics; Adjunct faculty member for the Tufts School of Medicine Master of Science program; Executive in Residence at Boston University’s School of Public Health; Founder of Access Solutions Consulting (ASC)

    Education: BA Economics, Boston University; MPH, Boston University School of Public Health/School of Medicine; MBA, Boston University Questrom School of Management

    Industry Organizations: Adjunct Faculty, Massachusetts College of Pharmacy and Health Sciences; Board Member, Massachusetts Association of Health Boards; Chair and Board Member, City of Framingham Board of Health; Board Member, The Genesis Foundation for Children; Member, American Cancer Society Cancer Action Network

    I’ve dedicated my career to driving access and innovation to patients and consumers, particularly in oncology, and helping to provide early screening and detection to cancer is a mission I have had at the core of my efforts. I look forward to working with this incredible team to expand colon cancer screening access for all.